Impact on Waitlist Outcomes from Changes in the Medical Eligibility of Candidates for Simultaneous Liver-Kidney Transplantation Following Implementation of the 2017 Organ Procurement and Transplantation Network/United Network for Organ Sharing Policy in the United States

18 February 2022 : Original article

Shingo Shimada^1ADEF*, Toshihiro Kitajima^1BCE, Yukiko Suzuki^1BD, Yasutaka Kuno^1BD, Tayseer Shamaa^1BC, Tommy Ivanics

^1BCE, Kelly Collins^1DE, Michael Rizzari^1BD, Atsushi Yoshida^1BD, Marwan Abouljoud^1BD, Dilip Moonka^2BD, Shunji Nagai^1ACE

DOI: 10.12659/AOT.934850

Ann Transplant 2022; 27:e934850

Background Material and Methods Results Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Table 2 The 90-day waitlist mortality risk and transplant probability after the 2017 policy (ref. before the 2017 policy).

	90-day waitlist mortality			90-day transplant probability
	aHR*	95% CI	P value	aHR*	95% CI	P value
	0.83	0.67–1.02	0.08	1.12	1.00–1.26	0.04

35 or higher	0.83	0.54–1.27	0.40	1.24	1.02–1.51	0.03
30–34	1.01	0.66–1.54	0.95	1.03	0.81–1.32	0.76
29 or lower	0.72	0.52–0.99	0.04	0.97	0.82–1.14	0.74
^* Hazards were adjusted by Fine-Gray model for recipient age, sex, race, Karnofsky score MELD score, at registration, presence of ascites, hepatic encephalopathy, dialysis requirement at registration and United Network for Organ Sharing (UNOS) region (1–11). aHR – adjusted hazard ratio; CI – confidence interval; MELD – model for end-stage liver disease.

Back to the Article